CLINICA CHIMICA ACTA 期刊简介

CLINICA CHIMICA ACTA
英文简介:

The Official Journal of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)
Clinica Chimica Acta is a high-quality journal which publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the diagnostic application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids and cells.

The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are only considered when they are clearly and directly relevant to human disease. Evaluation of commercial products have a low priority for publication, unless they are novel or represent a technological breakthrough. Studies dealing with effects of drugs and natural products and studies dealing with the redox status in various diseases are not within the journal's scope. Development and evaluation of novel analytical methodologies where applicable to diagnostic clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered. Studies focused on emerging diagnostic technologies and (big) data analysis procedures including digitalization, mobile Health, and artificial Intelligence applied to Laboratory Medicine are also of interest.

中文简介:(来自Google、百度翻译)

国际临床化学和实验室医学联合会 (IFCC) 官方期刊
Clinica Chimica Acta是一本高质量的期刊,在临床化学和实验室医学领域发表原创研究通讯,定义为化学的诊断应用,生物化学,免疫化学,血液学的生化方面,毒理学和分子生物学,用于研究体液和细胞中的人类疾病。
该杂志的目的是发布新颖的信息,从而更好地了解人类疾病的生物学机制,预防,诊断和患者管理。也欢迎有关应用临床特征的报告。与正常代谢过程或正常细胞或体液成分有关的论文,例如动物实验或临床研究的报告,仅在与人类疾病明确直接相关时才考虑。除非商业产品新颖或代表技术突破,否则对商业产品的评估优先级较低。有关药物和天然产物的影响的研究以及有关各种疾病中氧化还原状态的研究不在该杂志的范围之内。还将考虑开发和评估适用于诊断临床化学和实验室医学的新型分析方法,包括护理点测试,以及有关实验室管理和信息学的主题。针对新兴诊断技术和 (大) 数据分析程序 (包括数字化,移动健康和应用于实验室医学的人工智能) 的研究也很有趣。

期刊ISSN
0009-8981
影响指数
3.748
最新CiteScore值
5.30 查看CiteScore评价数据
最新自引率
4.10%
官方指定润色网址
https://www.deeredit.com/?type=ss1
投稿语言要求

Improve the quality of the paper, eliminate grammar and spelling errors, increase readability, ensure accurate communication of viewpoints, enhance academic reputation, and increase the chances of the paper being accepted.

建议点击这个网址:https://www.deeredit.com/?type=ss2,资深审稿专家为您评估稿件质量,提供针对性改进建议,最终可助您极大提升目标期刊录用率

期刊官方网址

hot

https://www.peipusci.com/?type=9
杂志社征稿网址

hot

https://www.peipusci.com/?type=10
通讯地址
ELSEVIER SCIENCE BV, PO BOX 211, AMSTERDAM, NETHERLANDS, 1000 AE
偏重的研究方向(学科)
医学-医学实验技术
出版周期
Monthly
出版年份
1956
出版国家/地区
NETHERLANDS
是否OA
No
SCI期刊coverage
Science Citation Index Expanded(科学引文索引扩展)
NCBI查询
PubMed Central (PMC)链接 全文检索(pubmed central)
CLINICA CHIMICA ACTA 期刊中科院JCR 评价数据
最新中科院JCR分区
大类(学科)
小类(学科)
综述期刊
医学
MEDICAL LABORATORY TECHNOLOGY(医学实验技术)2区
最新的影响因子
3.748
最新公布的期刊年发文量
年度总发文量 研究类文章占比
517 74.08%
总被引频次 127
影响因子趋势图
近年的影响因子趋势图(整体平稳趋势)

2022年预警名单预测最新

CLINICA CHIMICA ACTA 期刊CiteScore评价数据
最新CiteScore值
5.30
年文章数 517
SJR
0.924
SNIP
1.073
CiteScore排名
序号 类别(学科) 排名 百分位
1 Medicine Biochemistry (medical) #18/54
2 Medicine Clinical Biochemistry #40/113
3 Medicine Biochemistry #165/415
CiteScore趋势图
CiteScore趋势图
CLINICA CHIMICA ACTA 投稿经验(由下方点评分析获得,7人参与,7578人阅读)
投稿录用比例: 约50%
审稿速度: 约3.0个月
分享者 点评内容
没有更多了~
Copyright © 2014-2019 晟斯医学 All Rights Reserved. 备案号:苏ICP备11037034号-5 版权所有:南京孜文信息咨询有限公司